Vivo Opportunity Cayman, LLC (CIK 1930113) reported 30 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-16). Recent activity: Buy INM (4,882 shares), Buy INM (493 shares), Buy INM (13,761 shares), Buy INM (1,389 shares), Buy INM (19 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-16 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 4,882 | $7,567 |
| 2026-07-16 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 493 | $764 |
| 2026-07-16 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 13,761 | $21,330 |
| 2026-07-16 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 1,389 | $2,153 |
| 2026-07-16 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 19 | $29 |
| 2026-07-16 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 2 | $3 |
| 2026-07-02 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 55 | $85 |
| 2026-07-02 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 545 | $839 |
| 2026-07-02 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 3,946 | $6,116 |
| 2026-07-02 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 398 | $617 |
| 2026-07-02 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 1,460 | $2,263 |
| 2026-07-02 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 147 | $228 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 6,125 | $9,616 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 5,154 | $8,040 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 30,882 | $52,191 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 3,118 | $5,269 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 16,164 | $25,377 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 1,632 | $2,562 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 14,838 | $22,999 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 1,498 | $2,322 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 20,753 | $31,545 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 2,095 | $3,184 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 7,069 | $10,957 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 714 | $1,107 |
| 2026-06-10 | InMed Pharmaceuticals Inc. (INM) | 10% Owner | Buy | 51,056 | $79,647 |
Source: SEC Form 4 filings · as of 2026-07-16